I again listened to the last conference call and was impressed that promises for the past quarter eg. filing of an ANDA and completing a BE study was indeed accomplished.
NH also alluded to the fact that Kirkov, while he was prohibited from advancing sales of Adderall before April, was not prohibited from sales to other countries and this may be a nice surprise when we hear the Wednesday call.
Beside Adderall, Isradapine will also be an additional source of revenue as Kirkov will now service the distribution instead of EPIC.
As stated by King, he clearly indicated that Sequestox was basically dead unless a white knight, ( excuse the non woke expression) appears.
I remain bullish and expect this stock to trade break out when the 4 cent resistance level is breached.
News 
Market Data 
Discover 
